| A significant decrease of cutaneous microcirculation characterizes a soothing effect of the product. | |||||
|
| Before/after | ||||
| Subject | D0 | D28 | D56 | Δ D28 | Δ D56 |
| 1 | 154 | 147 | 153 | −7 | −1 |
| 2 | 165 | 140 | 153 | −25 | −12 |
| 3 | 193 | 186 | 183 | −7 | −10 |
| 4 | 184 | 175 | 185 | −9 | 1 |
| 5 | 158 | 141 | 147 | −17 | −11 |
| 6 | 202 | 167 | 177 | −35 | −25 |
| 7 | 158 | 149 | 160 | −9 | 2 |
| 8 | 221 | 198 | 186 | −23 | −35 |
| 9 | 200 | 183 | 183 | −17 | −17 |
| 10 | 185 | 155 | 165 | −30 | −20 |
| 11 | 137 | 140 | 137 | 3 | 0 |
| 12 | 166 | 149 | 155 | −17 | −11 |
| 13 | 155 | 151 | 156 | −4 | 1 |
| 14 | 160 | 161 | 165 | 1 | 5 |
| 15 | 107 | 114 | UN | 7 | UN |
| 16 | 205 | 196 | 200 | −9 | −5 |
| 17 | 135 | 144 | 135 | 9 | 0 |
| 18 | 151 | 149 | 142 | −2 | −9 |
| 19 | 106 | 109 | 110 | 3 | 4 |
| 20 | 142 | NC | 138 | NC | −4 |
| 21 | 134 | (157) * AV | 135 | (23) * AV | 1 |
| 22 | 158 | 167 | MV | 9 | MV |
| Mean | 162.5 | 156.1 | 158.3 | −9.0 | −7.3 |
| Median | 158.0 | 150.0 | 155.5 | −8.0 | −4.5 |
| Minimum | 106.0 | 109.0 | 110.0 | −35.0 | −35.0 |
| Maximum | 221.0 | 198.0 | 200.0 | 9.0 | 5.0 |
| SEM | 6.5 | 5.3 | 5.0 | 2.9 | 2.4 |
| CI 95% | 13.5 | 11.1 | 10.5 | 6.0 | 5.0 |
| Nb of subjects | 22 | 20 | 20 | 20 | 20 |
|
| Statistical analysis p = | 0.006 | 0.006 | ||
| Statistical test | T. test | T. test | |||
| Δ% | −4% | −3% | |||
| % of subjects with soothing effect (variation < −0.1) | 70% | 60% | |||